2 completed. 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow CYT-6091: new trials by email Literature Review of CYT-6091 trials Research Report on CYT-6091
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer colloidal gold-bound tumor necrosis factor, electron microscopy, pharmacological study - Adrenocortical Carcinoma, Breast Cancer | Early Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 108 | 2006-12-01 | 2012-05-02 |
| TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors colloidal gold-bound tumor necrosis factor, pharmacological study - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 60 | 2006-05-01 | 2012-03-15 |
Adrenocortical Carcinoma (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Fibrosarcoma (1) · Gastrointestinal Neoplasms (1) · Kidney Neoplasms (1) · Liver Neoplasms (1) · Melanoma (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1)
National Institutes of Health Clinical Center (CC) (2)
United States (2)
Steven A. Rosenberg, MD, PhD (1) · Steven K. Libutti, MD (1)